JMM Profile: Mycoplasma genitalium: a small, yet significant pathogen

  • the ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC)

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Mycoplasma genitalium is characterized by a small genome and a lack of a cell wall, contributing to its unique biology. It is associated with reproductive tract infections, including non-gonococcal urethritis and pelvic inflammatory disease. It is nearly as common as chlamydia in most studies from high-income countries. The emergence of antimicrobial resistance in M. genitalium raises concern about the long-term efficacy of current therapeutic strategies. Understanding its genomic intricacies and pathogenic mechanisms is crucial for developing targeted interventions to address the growing public health impact of this elusive microbe.

Original languageEnglish
Article number001984
JournalJournal of Medical Microbiology
Volume74
Issue number4
DOIs
Publication statusPublished - 4 Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • fluoroquinolones
  • macrolide resistance
  • non-gonococcal urethritis
  • Genome, Bacterial
  • Humans
  • Reproductive Tract Infections - microbiology - epidemiology
  • Urethritis - microbiology
  • Drug Resistance, Bacterial
  • Mycoplasma genitalium - genetics - pathogenicity - drug effects - physiology
  • Mycoplasma Infections - microbiology - epidemiology - drug therapy
  • Anti-Bacterial Agents - pharmacology - therapeutic use
  • Female
  • Pelvic Inflammatory Disease - microbiology

Cite this